临床路径在等离子消融髓核成形术治疗椎间盘源性腰痛的效果观察  

Effect of clinical pathway of percutaneous low-temperature disk plasma ablation on the treatment of lumbar disc herniation

作　　者：李卫星[1] 康健[1] 刘波[1] 程亮[1] 梁芳[1] 邹亿城[1] 陈海滨[1] 

机构地区：[1]东莞市太平人民医院疼痛科,广东东莞523900

出　　处：《泸州医学院学报》2015年第1期65-67,共3页Journal of Luzhou Medical College

基　　金：广东省科技厅科研计划项目(编号:粤科规划字[2013]137(4)号)

摘　　要：目的:分析等离子消融髓核成形术治疗椎间盘源性腰痛的临床路径(clinical pathway,CP)效果。方法:将120例椎间盘源性腰痛患者随机分为常规治疗组(简称对照组)60例和临床路径治疗组(简称CP组)60例,对照组采用常规的治疗模式,CP组采取临床路径治疗模式,对治疗后两组患者的平均住院天数、住院费用、抗生素使用天数、药费比、病人满意度、健康知识掌握情况等方面进行比较。结果:与对照组比较,治疗组患者的住院天数、住院费用、抗生素使用天数和药费比减少,病人满意度及健康知识掌握情况提高,均有统计学意义(P<0.05)。结论:临床路径可以节约医疗资源,提高社会效益,值得临床推广。Objective： To analyze the effects of clinical pathway on 60 patients with discogenic lumbago.Methods： 120 cases were randomly divided into the conventional therapy group（control group, n = 60）, and the clinical pathway therapy group（treatment group, n = 60）. The length of hospitalization,medical expenses,therapeutic satisfaction,and health awareness were compared between these two groups. Results： The length of hospitalization,medical expenses,therapeutic satisfaction,and health awareness of the treatment group were better than those of the control group（P〈0.05）. Conclusion： The Clinical pathway for intervertebral discs source lumbago could save medical resources and be worthy of clinical promotion.

关 键 词：临床路径 等离子消融髓核成形术 椎间盘源性腰痛 

分 类 号：R681.5[医药卫生—骨科学]